Search

everythinglearnresearchcommunity

for

Search:↓

Tyrosine kinase inhibitors for endocrine tumors often cause skin issues, requiring early management and treatment adjustments.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

Hair growth-promoting nutraceuticals do not block the cancer-fighting effects of tamoxifen and may enhance its action.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Liposomal anthracyclines are effective and safer for treating multiple myeloma, especially in elderly patients.

Imuvert can prevent some chemotherapy-induced hair loss.

Perhexiline can effectively target ovarian cancer cells left after treatment.

A scalp-cooling system effectively prevents hair loss in breast cancer patients treated with eribulin.

Hair loss can occur when stomach cancer spreads to the scalp.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

Sorafenib can cause delayed skin problems, so patients need careful monitoring.

Pulsed electric field treatment may help shrink untreated liver tumors.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

Dermoscopy helps diagnose unusual skin lesions like osteonevus of Nanta and can prevent misdiagnosis of serious conditions.

Nanoparticle systems make cancer treatment less toxic.

ATP helps prevent skin damage from vandetanib by reducing stress.

Nurses are crucial in managing chemotherapy side effects for ovarian cancer patients to improve their quality of life.

XMU-MP-1 stops cell growth in a human mini-organ and reduces the effectiveness of the chemotherapy drug paclitaxel.

Cancer treatments can cause various eye problems, so eye doctors should know how to diagnose and treat these early.

VYN201 shows promise as a safe and effective treatment for non-segmental vitiligo.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Vitamin A treatment reduced abnormal cell growth and improved skin conditions in rats with tumors.

GC10/DOX hydrogel shows promise as an effective thyroid cancer treatment.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.